Rho-kinase: important new therapeutic target in cardiovascular diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.00327.2011PMID 21622831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Cyclophilin A Promotes Cardiac Hypertrophy in Apolipoprotein E–Deficient Mice

  2011cited by this paper
• Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient mice

  2011cited by this paper
• Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.

  2011cited by this paper
• Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment.

  2011cited by this paper
• The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure

  2010cited by this paper
• Oxidative Stress and Vascular Smooth Muscle Cell Growth: A Mechanistic Linkage by Cyclophilin A

  2010cited by this paper
• Cyclophilin A: promising new target in cardiovascular therapy.

  2010cited by this paper
• Inflammation in atherosclerosis: transition from theory to practice.

  2010cited by this paper
• Abstract 11001: Cyclophilin a Mediates Pulmonary Vascular Remodeling by Rho-Kinase Activation in Patients With Pulmonary Hypertension

  2010cited by this paper
• Age-Related Changes in Redox Signaling and VSMC Function

  2010cited by this paper
• Abstract 16516: ROCK2 in Vascular Smooth Muscle Cells Plays a Crucial Role for Hypoxia-Induced Pulmonary Hypertension in Mice

  2010cited by this paper
• Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.

  2010cited by this paper
• Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.

  2010cited by this paper
• The role of Rho protein signaling in hypertension

  2010cited by this paper
• Contribution of Cyclophilin A to the Regulation of Inflammatory Processes in Rheumatoid Arthritis

  2009cited by this paper
• Rho-kinase is an important therapeutic target in cardiovascular medicine.

  2009cited by this paper
• PJ-247 Early, Simple, Noninvasive Predictors of Left Main or 3-Vessel Disease in Patients with Non-ST-segment Elevation Acute Coronary Syndromes(PJ042,ACS/AMI (Clinical/Diagnosis) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

  2009cited by this paper
• PJ-276 Unusual Veins Draining into the Left Atrial Chamber : Anatomical Investigation in 100 Autopsied Hearts(PJ047,Arrhythmia, Others (Clinical/Pathophysiology) 3 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

  2009cited by this paper
• ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells

  2009cited by this paper
• NADPH oxidase signaling and cardiac myocyte function.

  2009cited by this paper
• Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.

  2009cited by this paper
• Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest.

  2009cited by this paper
• Analysis of Pulmonary Vasodilator Responses to SB-772077-B [4-(7-((3-Amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a Novel Aminofurazan-Based Rho Kinase Inhibitor

  2009cited by this paper
• Adiponectin and cardiovascular disease.

  2009cited by this paper
• Molecular basis of restenosis and novel issues of drug-eluting stents.

  2009cited by this paper
• Cyclophilin A enhances vascular oxidative stress and development of angiotensin II-induced aortic aneurysms

  2009cited by this paper
• Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension.

  2009cited by this paper
• Understanding abdominal aortic aneurysm.

  2009cited by this paper
• Cyclophilin A Mediates Vascular Remodeling by Promoting Inflammation and Vascular Smooth Muscle Cell Proliferation

  2008cited by this paper
• ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.

  2008cited by this paper
• Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.

  2008cited by this paper
• Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure

  2008cited by this paper
• Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis

  2008cited by this paper
• Long-term Inhibition of Rho-kinase Ameliorates Diastolic Heart Failure in Hypertensive Rats

  2008cited by this paper
• NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II

  2007cited by this paper
• Development of Rho-kinase inhibitors for cardiovascular medicine.

  2007cited by this paper
• Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists.

  2007cited by this paper
• Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.

  2007cited by this paper
• Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats.

  2007cited by this paper
• Rho Kinase (ROCK) Inhibitors

  2007cited by this paper
• Role of oxidative stress in cardiac hypertrophy and remodeling.

  2007cited by this paper
• Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells.

  2007cited by this paper
• Sustained Elevation of Serum Cortisol Level Causes Sensitization of Coronary Vasoconstricting Responses in Pigs In Vivo: A Possible Link Between Stress and Coronary Vasospasm

  2006cited by this paper
• Rho kinases in cardiovascular physiology and pathophysiology.

  2006cited by this paper
• Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice

  2006cited by this paper
• Cyclophilin A Is Secreted by a Vesicular Pathway in Vascular Smooth Muscle Cells

  2006cited by this paper
• Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in Mice

  2006cited by this paper
• Deletion of p47phox Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E–Deficient Mice

  2006cited by this paper
• Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway

  2006cited by this paper
• Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages.

  2005cited by this paper
• Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine

  2005cited by this paper
• Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo.

  2005cited by this paper
• Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

  2005cited by this paper
• Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

  2005cited by this paper
• Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner

  2005cited by this paper
• ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles

  2005cited by this paper
• Functional Effects of Rho-Kinase–Dependent Phosphorylation of Specific Sites on Cardiac Troponin

  2005cited by this paper
• Rho-Kinase Inhibitor Improves Increased Vascular Resistance and Impaired Vasodilation of the Forearm in Patients With Heart Failure

  2005cited by this paper
• Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis

  2005cited by this paper
• Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice

  2004cited by this paper
• Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms

  2004cited by this paper
• Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice

  2004cited by this paper
• Rho and Rho Kinase Are Involved in Parathyroid Hormone‐Stimulated Protein Kinase C α Translocation and IL‐6 Promoter Activity in Osteoblastic Cells

  2004cited by this paper
• Angiotensin II-mediated development of vascular diseases.

  2004cited by this paper
• Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase

  2004cited by this paper
• Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition

  2004cited by this paper
• Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells.

  2004cited by this paper
• New Roles of Myosin II during Vesicle Transport and Fusion in Chromaffin Cells*

  2004cited by this paper
• C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats.

  2004cited by this paper
• Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats

  2004cited by this paper
• Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells

  2004cited by this paper
• Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms.

  2004cited by this paper
• Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm

  2003cited by this paper
• Reactive oxygen species in the vasculature: molecular and cellular mechanisms.

  2003cited by this paper
• Rho/Rho-Kinase Pathway in Brain Stem Contributes to Blood Pressure Regulation via Sympathetic Nervous System: Possible Involvement in Neural Mechanisms of Hypertension

  2003cited by this paper
• Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.

  2003cited by this paper
• Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II–Induced Atherosclerosis and Abdominal Aortic Aneurysms

  2003cited by this paper
• Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System

  2003cited by this paper
• Oxidative stress and cardiovascular injury: Part II: animal and human studies.

  2003cited by this paper
• Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal Death

  2003cited by this paper
• Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

  2003cited by this paper
• RhoE Binds to ROCK I and Inhibits Downstream Signaling

  2003cited by this paper
• GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila.

  2003cited by this paper
• ROCKs: multifunctional kinases in cell behaviour

  2003cited by this paper
• Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries

  2002cited by this paper
• Rho GTPases in cell biology

  2002cited by this paper
• Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases

  2002cited by this paper
• Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats.

  2002cited by this paper
• Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.

  2002cited by this paper
• Anti-anginal Effect of Fasudil, a Rho-Kinase Inhibitor, in Patients With Stable Effort Angina: A Multicenter Study

  2002cited by this paper
• Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury

  2001cited by this paper
• Antianginal effects of hydroxyfasudil, a Rho‐kinase inhibitor, in a canine model of effort angina

  2001cited by this paper
• Antiischemic properties of fasudil in experimental models of vasospastic angina.

  2001cited by this paper
• Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo.

  2001cited by this paper

• Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management.

  2026cites this paper
• Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations

  2025cites this paper
• Pharmacological Evaluation of Nanoformulated Phloretin against Myocardial Ischemia with Mechanistic Validation via Molecular Docking and Dynamics.

  2025cites this paper
• Rho/ROCK Pathway as a Therapeutic Target in Multiple Diseases

  2025cites this paper
• Fasudil protects spiral ganglion neurons and hair cells against cisplatin-induced apoptosis by inhibiting reactive oxygen species accumulation and regulating the ROCK/PTEN/AKT signaling pathway.

  2025cites this paper
• Myosin light chain phosphatase is a downstream target of Rho-kinase in endothelin-1-induced transactivation of the TGF-β receptor

  2024cites this paper
• The Application of Rho Kinase Inhibitors in the Management of Glaucoma

  2024cites this paper
• SLIT3 promotes cardiac fibrosis and differentiation of cardiac fibroblasts by RhoA/ROCK1 signaling pathway

  2024cites this paper
• Fasudil alleviates alcohol-induced cognitive deficits and hippocampal morphology injury partly by altering the assembly of the actin cytoskeleton and microtubules.

  2024cites this paper
• Annexin A1 protects epidermal stem cells against ultraviolet-B irradiation-induced mitochondrial dysfunction

  2024cites this paper
• RhoA/rho kinase pathway activation in age‐associated endothelial cell dysfunction and thrombosis

  2024cites this paper
• Causal links between blood inflammation markers and postherpetic neuralgia risk: insights from a two-sample Mendelian randomization study

  2024cites this paper
• Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation

  2023cites this paper
• Direct active Fyn-paxillin interaction regulates vascular smooth muscle cell migration

  2023cites this paper
• RhoA/ROCK1 regulates the mitochondrial dysfunction through Drp1 induced by Porphyromonas gingivalis in endothelial cells

  2023cites this paper
• ROCK2 interacts with p22phox to phosphorylate p47phox and to control NADPH oxidase activation in human monocytes

  2023cites this paper
• Uncaria Rhynchophylla attenuates angiotensin Ⅱ-induced myocardial fibrosis via suppression of the RhoA/ROCK1 pathway.

  2022cites this paper
• KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease

  2022cites this paper
• Progress in the Treatment of Coronary Microvascular Dysfunction

  2022cites this paper
• Antispastic Effect of Fasudil and Cocktail of Fasudil and Nitroglycerin in Internal Thoracic Artery.

  2022cites this paper
• Immunogenic cell death in mice expressing caspase-resistant ROCK1 is not replicated by ROCK inhibitors

  2022cites this paper
• Mechanistic Insights into Atrial Fibrillation in Dialysis Patients with End-Stage Renal Disease: The Roles of Rho Kinase Activity and Connexin 40

  2022cites this paper
• Immunogenic Death of Hepatocellular Carcinoma Cells in Mice Expressing Caspase-Resistant ROCK1 Is Not Replicated by ROCK Inhibitors

  2022cites this paper
• Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate

  2022cites this paper
• Current update on theranostic roles of cyclophilin A in kidney diseases

  2022cites this paper
• Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial ischemia/reperfusion.

  2022cites this paper
• Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?

  2022cites this paper
• Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke

  2022cites this paper
• Increase of serum Cyclophilin C levels in the follow-up of coronary artery disease: A biomarker and possible clinical predictor

  2021cites this paper
• Thomas Willis Lecture

  2021cites this paper
• The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease

  2021cites this paper
• The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension

  2021cites this paper
• Quercetin ameliorated remote myocardial injury induced by renal ischemia/reperfusion in rats: Role of Rho-kinase and hydrogen sulfide.

  2021cites this paper
• Discovery of Cellular RhoA Functions by the Integrated Application of Gene Set Enrichment Analysis

  2021cites this paper
• Inhibiting the ROCK Pathway Ameliorates Acute Lung Injury in Mice following Myocardial Ischemia/reperfusion

  2021cites this paper
• Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways

  2021cites this paper
• Drug discovery focused on novel pathogenic proteins for pulmonary arterial hypertension.

  2021cites this paper
• Crocetin Exerts a Cardio-protective Effect on Mice with Coxsackievirus B3-induced Acute Viral Myocarditis.

  2021cites this paper
• New susceptibility alleles associated with severe coronary artery stenosis in the Lebanese population

  2021cites this paper
• MRTFA overexpression promotes conversion of human coronary artery smooth muscle cells into lipid-laden foam cells.

  2021cites this paper
• Mechanisms of medicinal plant activity on nitric oxide (NO) bioavailability as prospective treatments for atherosclerosis.

  2020cites this paper
• ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements

  2020cites this paper
• Discovery of thieno[2,3-d]pyrimidin-4(3H)-one derivatives as a new class of ROCK inhibitors.

  2020cites this paper
• Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients

  2020cites this paper
• Targeting ROCK signaling in health, malignant and non-malignant diseases.

  2020cites this paper
• Cyclophilin A and matrix metalloproteinase-9: Their relationship, association with, and diagnostic relevance in stable coronary artery disease

  2020cites this paper
• Vascular smooth muscle stiffness and its role in aging.

  2020cites this paper
• Tetrahydroxystilbene glucoside protects against LPS-induced endothelial dysfunction via inhibiting RhoA/ROCK signaling and F-actin remodeling.

  2020cites this paper
• Cytoprotective Effect of Rho Kinase Inhibitors against Oxidative Stress inTrabecular Meshwork Cells

  2020cites this paper
• Embryonic development of bicuspid aortic valves.

  2020cites this paper
• Design of novel ROCK inhibitors using fragment-based de novo drug design approach

  2020cites this paper
• An Update on the Association of Protein Kinases with Cardiovascular Diseases.

  2019cites this paper
• Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathway

  2019influential citation
• Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.

  2019cites this paper
• Mechanism of H2S-mediated ROCK inhibition of total flavones of Rhododendra against myocardial ischemia injury

  2019cites this paper
• Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.

  2019cites this paper
• Coptisine from Coptis chinensis exerts diverse beneficial properties: A concise review

  2019cites this paper
• Reduced cardiac ischemia/reperfusion injury by hypothermic reperfusion via activation of transient receptor potential M8 channel.

  2019cites this paper
• Rho-kinase inhibitor attenuates airway mucus hypersecretion and inflammation partly by downregulation of IL-13 and the JNK1/2-AP1 signaling pathway.

  2019cites this paper
• Urotensin-#receptor antagonist SB-706375 protected isolated rat heart from ischaemia–reperfusion injury by attenuating myocardial necrosis via RhoA/ROCK/RIP3 signalling pathway

  2019cites this paper
• RhoGTPase in Vascular Disease

  2019cites this paper
• BKCa compensates impaired coronary vasoreactivity through RhoA/ROCK pathway in hind‐limb unweighted rats

  2019cites this paper
• Cardiovascular Physiology

  2019cites this paper
• Cyclophilin A: a novel biomarker for cardiovascular disease in patients with type 2 diabetes

  2019cites this paper
• Exercise and the Coronary Circulation

  2019cites this paper
• Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug.

  2019cites this paper
• Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy

  2019cites this paper
• Rho-kinase is a negative regulator of red blood cell eNOS under basal conditions

  2019cites this paper
• Recent Advances in the Development of Cardiovascular Biomarkers

  2018cites this paper
• SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes

  2018cites this paper
• Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension

  2018cites this paper
• Einfluss von Statinen auf die Gefäßfunktion bei diätinduzierter Adipositas

  2018cites this paper
• Rho kinase, a potential target in the treatment of metabolic syndrome.

  2018cites this paper
• Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms

  2018cites this paper
• CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.

  2018cites this paper
• Peptide modulators of Rac1/Tiam1 protein‐protein interaction: An alternative approach for cardiovascular diseases

  2018cites this paper
• The effect of a Rho–kinase inhibitor (Y-27632) on the relaxation of thromboxane a 2 mimetic (U-46619) induced contraction in the presence and absence of the endothelium

  2018cites this paper
• Reverse Engineering Glaucoma

  2018cites this paper
• Partial contribution of Rho-kinase inhibition to the bioactivity of Ganoderma lingzhi and its isolated compounds: insights on discovery of natural Rho-kinase inhibitors

  2017cites this paper
• Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Coronary Artery Disease

  2017cites this paper
• Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho‐kinase pathway and NADPH oxidase

  2017cites this paper
• RhoA inhibits the hypoxia-induced apoptosis in osteoblasts

  2017cites this paper
• Effects of fasudil on pulmonary hypertension in clinical practice.

  2017cites this paper
• Idiopathic Pulmonary Arterial Hypertension in Children: A Review

  2017cites this paper
• Rho-Kinase as a Therapeutic Target for Pulmonary Hypertension

  2017cites this paper
• Development of Novel Therapies for Cardiovascular Diseases by Clinical Application of Basic Research.

  2017cites this paper
• Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

  2017cites this paper
• Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics

  2017cites this paper
• In silico prediction of ROCK II inhibitors by different classification approaches

  2017cites this paper
• Effect of fasudil on restenosis after balloon injury in rats

  2017cites this paper
• Rho‐kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats

  2017cites this paper
• Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells

  2017cites this paper
• Diagnostic Value of Cyclophilin A in Acute Ischemic Stroke

  2017cites this paper
• Myofibroblast-Mediated Contraction.

  2017cites this paper
• Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

  2017cites this paper
• Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells

  2017cites this paper
• ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy

  2017cites this paper
• Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.

  2017cites this paper
• 78 – Regulation of Pulmonary Circulation

  2017cites this paper
• Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

  2017cites this paper